Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels

作者
Peter Suenaert,Anneleen Segers,Leen Rymenans,Helene Devroye,Janne Marie Moll,Patrice D. Cani,Willem M. de Vos
出处
期刊:Gut microbes [Landes Bioscience]
卷期号:18 (1): 2690689-2690689 被引量:7
标识
DOI:10.1080/19490976.2026.2690689
摘要

Pasteurized Akkermansia muciniphila MucT was found to improve barrier function in preclinical models and a proof-of-concept study in obese and prediabetic adults. Here, we describe the results of a double-blind placebo-controlled multicenter (Ireland and Germany) trial in 142 adults with metabolic syndrome, with or without prediabetes. The primary endpoint of whole-body insulin sensitivity (Matsuda index) did not differ after 4-months of daily administration of capsules containing 30 billion cells of pasteurized A. muciniphila MucT compared to placebo in the intention-to-treat subjects. Subsequent exploratory analyses showed that 3-months intake of pasteurized A. muciniphila MucT already improved HOMA-based hepatic insulin sensitivity in prediabetic (12%; p = 0.05) and 63-y-or-older-age subgroups (p = 0.05) while increasing post-OGTT excursion of the insulinotropic hormone glucagon-like peptide 1 (GLP-1) over placebo (p < 0.01). Further analysis of the gut microbiota by deep metagenomic analysis showed minor effects of the intervention but revealed that the baseline microbial composition differed from that in matched healthy adults. We found that participants with low baseline Akkermansia gene counts experienced significant health improvements and GLP-1 excursion after 3-months of treatment with pasteurized A. muciniphila MucT over the placebo. These benefits included improved insulin sensitivity (as shown by Matsuda and HOMA-S indices) and GLP-1 excursion (post-OGTT) (p < 0.05), reductions in body weight (p = 0.06) and decreased trunk fat (p < 0.05). In conclusion, daily supplementation with pasteurized A. muciniphila MucT has the potential to improve health markers in overweight or obese normo- or dysglycemic adults with the most significant improvements in subjects with low baseline intestinal Akkermansia levels, who are apparently truly in need of this intervention. Clinical trial registration no.: NCT05114018 clinicaltrials.gov.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Sign发布了新的文献求助10
刚刚
1秒前
找到了没完成签到,获得积分10
1秒前
魈玖完成签到,获得积分10
1秒前
ll完成签到,获得积分10
1秒前
shawn_89完成签到,获得积分10
1秒前
2秒前
wdw2501发布了新的文献求助10
2秒前
哈基咪完成签到,获得积分10
2秒前
风吹麦浪的应助被tianfx3采纳,获得10
2秒前
隐形曼青的应助被笨笨的含莲采纳,获得10
3秒前
张继科keke发布了新的文献求助10
3秒前
动听的秋灵完成签到,获得积分10
3秒前
酸甜完成签到,获得积分10
3秒前
爆米花的应助被Bilibala采纳,获得10
3秒前
4秒前
lixm316完成签到,获得积分10
4秒前
sink发布了新的文献求助10
4秒前
Flyzhang完成签到,获得积分10
4秒前
毛果果发布了新的文献求助10
4秒前
4秒前
4秒前
派先生丶的应助被cc采纳,获得10
4秒前
科研通AI2S的应助被时尚丸子采纳,获得10
4秒前
111完成签到,获得积分10
5秒前
研友_wZr5Rn发布了新的文献求助10
5秒前
无语的怜梦完成签到,获得积分10
5秒前
zad完成签到,获得积分10
5秒前
甜甜的契完成签到,获得积分10
5秒前
l895365038发布了新的文献求助10
6秒前
6秒前
huimin发布了新的文献求助10
6秒前
wangjian完成签到,获得积分10
6秒前
ksduoiwex完成签到,获得积分10
7秒前
就是好命完成签到,获得积分10
7秒前
7秒前
共享精神的应助被小杰采纳,获得10
7秒前
Akim的应助被调皮枫叶采纳,获得10
7秒前
霍双帅完成签到 ,获得积分10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159581
求助须知:如何正确求助?哪些是违规求助? 9555100
关于积分的说明 21724719
捐赠科研通 7749543
什么是DOI,文献DOI怎么找? 3427281
关于科研通互助平台的介绍 2552278
邀请新用户注册赠送积分活动 2471619